Found 12 matching trials
Pulse Wave Velocity, Tacrolimus Time in Therapeutic Range and CV in African American Kidney Transplants PHASE4 The primary purpose of this study is to evaluate the pulse wave velocity an...
Show More Status
Active Not Recruiting
Location
Hospital of the University of Pennsylvania
Learn More & Join Trial
Neurocognitive Function Changes With Extended-Release Tacrolimus Among Older Kidney Transplant Recipients PHASE4 The objective of this randomized controlled study is to assess the neurocog...
Show More Location
MGH Kidney Transplant Clinic
Learn More & Join Trial
Efficacy of Envarsus XR and Digital Health Technology in Reducing Tacrolimus Fluctuation and Frequency of Dose Changes NA Tacrolimus is an immunosuppressive agent prescribed to prevent organ reject...
Show More Location
Multiple Locations
Learn More & Join Trial
Crossover Study to Compare PK of Once Daily LCP-Tacro Tablets to Generic Tacrolimus Capsules Twice Daily. PHASE3 Open label, prospective, single-center, randomized, two sequence, three per...
Show More Location
University of Illinois, Chicago
Learn More & Join Trial
Once-daily Regimen With Envarsus® to Optimize Immunosuppression Management and Outcomes in Kidney Transplant Recipients NA With the availability of well-studied once-daily formulations of tacrolimus...
Show More Location
Medical University of South Carolina
Learn More & Join Trial
Effect of Tacrolimus Formulation on Neurological Side Effects in Older Kidney Transplant Recipients PHASE4 Previous studies have shown that elderly patients experience higher trough ...
Show More Learn More & Join Trial
Renal Tubular Injury and Transplant Outcomes in Cardiac Recipients Converting From IR Tacrolimus to XR Tacrolimus PHASE4 Immediate release (IR) tacrolimus peaks in the first two hours after admini...
Show More Location
Loyola University Medical Center
Learn More & Join Trial
Early Use of Long-acting Tacrolimus in Lung Transplant Recipients EARLY_PHASE1 Lung transplantation is a life-saving therapy for patients with advanced lu...
Show More Location
Vanderbilt University Medical Center
Learn More & Join Trial
Real-word Study of the de NOVO Extended-release tacrolimuS in Kidney Transplantation Using an ARTificial Intelligence N/A The purpose of this study is to assess the clinical efficacy of the LCPT En...
Show More Learn More & Join Trial
Dose-Expansion Study of Low Dose Post-Transplant Cyclophosphamide/Tacrolimus/Ruxolitinib for Graft-versus-Host Disease (GVHD) Prophylaxis in Myeloablative Allogeneic Peripheral Blood Stem Cell Transplantation PHASE2 This is an open label, non-randomized, multicenter, pilot, dose expansion s...
Show More Location
Ohio State University Comprehensive Cancer Center
Learn More & Join Trial